A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Osteoporosis, Postmenopausal Syndrome |
| Therapuetic Areas: | Endocrinology, Rheumatology |
| Healthy: | No |
| Age Range: | 55 - 85 |
| Updated: | 4/21/2016 |
| Start Date: | June 2015 |
| End Date: | September 2015 |
An Open-label Crossover Study to Determine the Patient Preference Between ZP-PTH Patches and Forteo Pens After Daily Treatment for 14 Days in Women 55-85 Years of Age
The purpose of this study is to determine which of two delivery methods of Parathyroid
Hormone (PTH) is preferred by patients after 14 days of use for each.
Hormone (PTH) is preferred by patients after 14 days of use for each.
The purpose of this study is to determine which of two delivery methods of PTH is preferred
by patients after 14 days of use for each. Patient preference will be determined by means of
patient questionnaires at the end of each treatment period and a final questionnaire after
both treatment periods are complete. Adverse events will also be collected.
by patients after 14 days of use for each. Patient preference will be determined by means of
patient questionnaires at the end of each treatment period and a final questionnaire after
both treatment periods are complete. Adverse events will also be collected.
Inclusion Criteria:
- Postmenopausal with prior diagnosis of osteoporosis
Exclusion Criteria:
- Significant health issue
- previous use of teriparatide
- History of Paget's disease
We found this trial at
1
site
Click here to add this to my saved trials
